Just In
- 2 hrs ago What Your Tongue Reveals About Your Health: Wellness And Warning Signs You Need To Know
- 3 hrs ago How Can You Protect Yourself From Extreme Heat? Dos And Don’ts To Follow
- 7 hrs ago Daily Horoscope, 23 April 2024: Cancer Will Have A Good Day In Terms Of Finances
- 12 hrs ago Hanuman Jayanti 2024: Hanuman Chalisa Lyrics With Meaning, When And How Many Times To Recite It
Don't Miss
- Movies Anne Hathaway REVEALS 'Gross' Hollywood Audition Practices, Know What Bizarre Thing Happened With Oscar-Winner
- Finance 1:1 Bonus Issue: Engineering Stock Turned Ex-Bonus On April 23, Hits New 52-Week High; Gives 268% Returns
- Education Mizoram 10th Results to be declared Soon at mbse.edu.in, Check the Tentative Date
- News Not Hardik Pandya, Rohit Sharma Is Still Captain For Many Mumbai Indian Players: Irfan Pathan
- Technology Meta Quest OS is now Opened to Third-Party Hardware Manufacturers: Rebranded as Meta Horizon OS
- Sports IPL 2024: 'Sunil takes offf the pressure from Me' - KKR star Phil Salt on dynamic partnership
- Automobiles Suzuki Access Electric To Electrify The Indian Scooter Market By 2024
- Travel Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Booster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both - Covishield as the first dose and Covaxin as the second dose - in the context of the Omicron variant, a study done by the National Institute of Virology (NIV) in Pune has indicated. The heterologous vaccination regimen of administering the first dose of Covishield, followed by the second dose of Covaxin had given a very good neutralising response against Delta and other Variants of Concern, Dr Pragya Yadav, a scientist at the NIV, said.
The study involved three cohorts -- a heterologous group with 18 individuals who were inadvertently administered the first dose of Covishield and the second dose of Covaxin in Uttar Pradesh and two groups comprising 40 individuals each receiving two doses of homologous Covishield or Covaxin.
"All the three groups were closely monitored. When we analysed the cohorts in June last year, the heterologous vaccination regimen of administering the first dose of Covisheid, followed by the second dose of Covaxin showed a very good neutralising antibody response against Delta and other Variants of Concern, as compared to the two other cohorts," Yadav said.
The study findings have been published in the Journal of Travel Medicine. "The gradual shift of VoCs from Delta to Delta-sub-lineage to Omicron, along with the observed waning of immunity post six months of vaccination, has prompted discourses around devising an innovative vaccination strategy.
The present investigation findings contribute meaningfully to such discussions. Regardless of the findings of this study, longitudinal monitoring for breakthrough infections should remain a part of any surveillance system," the study stated.
India began administering the precautionary doses of the COVID-19 vaccines to the healthcare and frontline workers and those aged 60 years and above with comorbidities from January 10.
The Union health ministry removed the comorbidity clause recently, making everyone aged above 60 years eligible for the precautionary dose of the Covid vaccines. The vaccination of children aged 12-14 years started from March 16.
Photo: DW
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- wellnessCovishield Dose Gap Reduced To 8-16 Weeks From 12-16
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval
- healthMedia Reports Stating Vaccine Shortage In Maharashtra Are Not Factually Correct: Govt
- healthCovovax Better Booster For Covishield-Vaccinated People: Dr Shahid Jameel, Virologist
- healthCovishield Protection Wanes After Three Months, Lancet Study Finds
- healthCovishield's Effectiveness In Fully Vaccinated Individuals 63% During 2nd Wave, Study
- healthSerum Institute Urges Govt To Fast-Track Movement Of Increasing Covishield Stock
- healthGovernment Allows Serum Institute To Export 50 Lakh Covishield Doses Under Covax To 4 Nations
- healthCovishield May Offer Over 90% Protection Against Death From Delta Variant: Study
- disorders cureMixing And Matching Of COVID-19 Vaccine Doses? Is It Safe?